Large cell change (ICC), characterized by cellular enlargement, nuclea
r pleomorphism and hyperchromasia, and multinucleation of hepatocytes,
is a common lesion in cirrhotic livers, but its nature, significance,
and pathogenesis remain uncertain. Therefore, we assessed the prognos
tic value of LCC as a marker of subsequent hepatocellular carcinoma (H
CC) through a case-control study that compared pretransplant liver bio
psy specimens from 37 cirrhotic liver transplant recipients with HCC t
o specimens from a control,group of recipients without HCC, matched fo
r sex, age (+/-5 years), and cause of cirrhosis. LCC was identified in
16 (43%) of the study and 7 (19%) of the control group biopsy specime
ns. By matched-pair analysis, LCC conveyed a moderately increased risk
of later HCC with an estimated odds ratio of 3.3 (95% CI, 1.2-15; P =
.038). However, a pathology review of 45 HCCs showed adjoining LCC in
only 12 (27%) and did not suggest a morphological transition or a his
togenetic association between the two lesions. LCC hepatocytes display
ed a low proliferative rate by Ki-67 or proliferating cell nuclear ant
igen immunostaining (labeling indices of 0.27 and 0.73) but showed a g
reater degree of apoptosis than normal hepatocytes (labeling indices o
f 1.9 and 0.23; P = .03) To reconcile these findings, we propose that
LCC derives from derangements in the hepatocyte's normal process of po
lyploidization. Such derangements, possibly caused by chronic inflamma
tion-induced DNA damage, could yield a population of enlarged liver ce
lls with nuclear atypia and pleomorphism, frequent binuclearity, and m
inimal proliferation. According to this hypothesis, LCC would be a hab
itual feature of cirrhosis and a regular accompaniment of HCC but woul
d not represent a direct malignant precursor.